A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01665430 · TERMINATED
Trial details
- NCT number
- NCT01665430
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-02-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.